1-Deoxynojirimycin (DNJ), a natural polyhydroxylated piperidine alkaloid, is attracting growing attention due to its important biological functions. This paper introduces the discovery and origins of DNJ, its extraction, purification, and physiological functions in the treatment of diabetes. The mechanisms of DNJ in the inhibition of fat accumulation and tumor cell metastasis are also discussed. In addition, the prospects and challenges of DNJ for practical production are proposed. This work aims to provide technical advice on obtaining DNJ and a fuller understanding of its biological activities.
YagiM, KounoT, AoyagiY, MuraiH. (1976) The structure of moraoline, a piperidine alkaloid from Morus species. Nippon Nougei Kagaku Kaishi, 50, 571–572.
2.
SteinDC, KopecLK, YasbinRE, YoungFE. (1984) Characterization of Bacillus subtilis DSM704 and its production of 1-deoxynojirimycin. Applied and Environmental Microbiology, 48, 280–284
3.
HardickDJ, HutchinsonDW. (1993) The biosynthesis of 1-deoxynojirimycin in Bacillus subtilis var niger. Tetrahedron Letters, 49, 6707–6716
4.
OnoseS, IkedaR, NakagawaK, KimuraT, YamagishiK, HiguchiO, MiyazawaT. (2013) Production of the α-glycosidase inhibitor 1-deoxynojirimycin from Bacillus species. Food Chemistry, 138, 516–523.
5.
EzureY, MaruoS, MiyazakiK, KawamataM. (1985) Moranoline (1-deoxynojirimycin) fermentation and its improvement. Agricultural and Biological Chemistry, 49, 1119–1125
6.
HardickDJ, HutchinsonDW, TrewSJ, WellingtonEMH. (1991) The biosynthesis of deoxynojirimycin and deoxymannonojirimycin in Streptomyces subrutilus. Journal of the Chemical Society-Chemical Communications10, 729–730
7.
PaekNS, KangDJ, LeeHS, KimTH, KimKW. (1997) Production of 1-deoxynojirimycin by Streptomyces sp. SID9135. Journal of Microbiology and Biotechnology, 7, 262–266
8.
InouyeS, TsuruokaT, NidaT. (1966) The structure of nojirimycin, a piperidinose sugar antibiotic. Journal of Antibiotics, 19, 288–292.
9.
AsanoN, KatoA, MiyauchiM, KizuH, KamedaY, WatsonAA, NashRJ, FleetGW. (1998) Nitrogen-containing furanose and pyranose analogues from Hyacinthos oricntalis. Journal of Natural Products, 62, 625–628.
ShibanoM, FujimotoY, KushinoK, KusanoG, BabaK. (2004) Biosynthesis of 1-deoxynojirimycin in Commelina communis: A difference between the microorganisms and plants. Phytochemistry, 65, 2661–2665
12.
ShibanoM, KakutaniK, TaniguchiM, YasudaM, BabaK. (2008) Antioxidant constituents in the dayflower (Commelina communis L.) and their alpha-glucosidase-inhibitory activity. Journal of Natural Medicines, 62, 349–353.
13.
AsanoN, NishidaM, MiyauchiM, lkedaK, YamamotoM, KizuH, KamedaY, WatsonAA, NashRJ, FleetGW. (2000) Polyhydroxylated pyrrolidine and piperidine alkaloids from Adenophora triphylla var. japonica (Campanulaeeae). Phytochemistry, 53, 379–382.
14.
YasudaK, KizuH, YamashitaT, KamedaY, KatoA, NashRJ, FleetGW, MolyneuxRJ, AsanoN. (2002) New sugar-mimic alkaloids from the pods of Angylocalyx pynaertii. Journal of Natural Products, 65, 198–202.
15.
YinH, ShiXQ, SunB, YeJJ, DuanZA, ZhouXL, CuiWZ, WuXF. (2010) Accumulation of 1-deoxynojirimycin in silkworm, Bombyx mori L. Journal of Zhejiang University. Science B, 11, 286–291
16.
AsanoN, YamashitaT, YasudaK, IkedaK, KizuH, KamedaY, KataA, NashRJ, LeeHS, RyuKS. (2001) Polyhydroxylated alkaloids isolated from mulberry trees (Morus alba L.) and silkworms (Bombyx mori L.). Journal of Agricultural and Food Chemistry, 49, 4208–4213.
YoshikuniY, EzureY, AoyagiY, EnomotoH. (1988) Inhibition of intestinal alpha-glucosidase and postprandial hyperglycemia by N-substituted moranoline derivatives. Journal of Pharmacobio-dynamics, 11, 356–362.
19.
KimuraM, ChenF. (1995) Antihyperglycemic effects of N-containing sugars derived from mulberry leaves in streptozococin-induced diabetic mice. Wakan Lyakugaku Zasshi, 12, 214–219
20.
KimJY, OkHM, KimJ, ParkSW, KwonSW, KwonO. (2015) Mulberry leaf extract improves postprandial glucose response in prediabetic subjects: a randomized, double-blind placebo-controlled trial. Journal of Medicinal Food, 18, 306–313.
21.
TsudukiT, NakamuraY, HonmaT, NakagawaK, KimuraT, IkedaI, MiyazawaT. (2009) Intake of 1-deoxynojirimycin suppresses lipid accumulation through activation of the beta-oxidation system in rat liver. Journal of Agricultural and Food Chemistry, 57, 11024–11029.
22.
WangRJ, YangCH, HuML. (2010) 1-Deoxynojirimycin inhibits metastasis of B16F10 melanoma cells by attenuating the activity and expression of matrix metalloproteinases-2 and –9 and altering cell surface glycosylation. Journal of Agricultural and Food Chemistry, 58, 8988–8993.
TaoF, HeY, YangQG, WangF, ChenYP, ChenGH, WeiZJ. (2012) Effects of 1-deoxynojirimycin on age-related changes in sensorimotor ability and anxiety in SAMP8 mice. Journal of Anhui Agricultural University, 3, 341–344
25.
ChenGH, TongJJ, WangF, HuXQ, LiXW, TaoF, WeiZJ. (2015) Chronic adjunction of 1-deoxynojirimycin protects from age-related behavioral and biochemical changes in the SAMP8 mice. Age (Dordrecht, Netherlands), 37, 102–126.
26.
BalzariniJ. (2007) The alpha(1,2)-mannosidase l inhibitor l-deoxymannojirimyein potentiates the antiviral activity of carbohydrate-binding agents against wild-type and mutant HIV-1 strains containing glyean deletions in gP120. FEBS Letters, 581, 2060–2064
27.
GrutersRA, NeefjesJJ, TersmetteM, de GoedeRE, TulpA, HuismanHG, MiedemaF, PloeghHL. (1987) Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase. Nature, 330, 74–77
28.
MehtaA, ZitzmannN, RuddPM, BlockTM, DwekRA. (1998) Alpha-glucosidase inhibitors as potential broad based anti-viral agents. FEBS Letters, 23, 17–22.
29.
KimuraT, NakagawaK, KubotaH, KojimaY, YamaqishiK, OitaS, OikawaS, MiyazawaT. (2007) Food-grade mulberry powder enriched with 1-deoxynojirimycin suppresses the elevation of postprandial blood glucose in humans. Journal of Agricultural and Food Chemistry, 55, 5869–5874
30.
LiH, QiangYH, WangJF, XiaoNK. (2006) Determination of 1-deoxynojirimycin (DNJ) in mulberry leaves by gas phase. North Sericulture, 3, 31–32
31.
LongL, YangY, ZhuNS. (2016) Colorimetric method in the determination of 1-deoxynojirimycin isolated from the mutant strain of Bacillus subtilis. Biotechnology Bulletin, 6, 187–192
32.
ChenZY, XiaoGS, ChenWD, LiuXM, WuJJ, LiSF, ZhengL. (2004) Determination of 1-deoxynojirimycin in yellow blood silkworm by ion chromatography. Food Science, 5, 150–151
33.
LiYG, ChuYN, ZhongSL, ZhiQ, LinT.B, JiDF. (2010) DNJ contents in leaves of 59 wild mulberry species and inhibitive activities of the leaf crude extract to α-glycosidase. Science Sericulture (Article in Chinese), 5, 729–737.
34.
YatsunamiK, IchidaM, OnoderaS. (2008) The relationship between 1-deoxynojirimycin content and alpha-glucosidase inhibitory activity in leaves of 276 mulberry cultivars (Morus spp.) in Kyoto, Japan. Journal of Natural Medicines, 62, 63–66.
35.
ChenHJ, ShiY, LiuJ, MuLX, ZouYX, LiaoST. (2014) Changes of 1-deoxynojirimycin with hypoglycemic activity in silkworm (Bombyx mori L.) during different developmental stages. Medicinal Chemistry, 4, 630–634.
36.
LiuWQ, ZhuXR. (2006) The determination of 1-deoxynojirimycin (DNJ) in three parts of the mulberry. Bulletin of Sericulture, 4, 31–34.
37.
OuYZ, ChenJ. (2004) Determination of 1-deoxynojirimycin in Morus alba L. leaves in different seasons. Food Science, 10, 221–214.
38.
LiuMY, YuG, WangH. (2006) The progress of the concentration technology of extract of traditional Chinese medicine (Article in Chinese). Zhongguo Zhong Yao Za Zhi, 31, 184–187.
39.
ZhangHY, WangTC, LiuJZ, HuJX, LiuCL. (2011) Determination and analysis of 1-deoxynojirimycin content in latex of mulberry branch (Article in Chinese). Science Sericulture, 1, 121–124.
40.
HuRJ, CheZM. (2008) Studies on the microwave-assisted extraction method of DNJ from mulberry leaves (Article in Chinese). Journal of Food Engineering, 1, 50–53.
41.
GuXD, JiGS, LiQ, FeiJJ, FengYY, LiTC. (2013) Mulberry leaf DNJ extracted through microbial pretreatment and inhibitory effect of extract on β-glucosidase. Science Sericulture, 4, 756–762.
42.
JiangYG, WangCY, JinC, JiaJQ, GuoXJ, ZhangGZ, GuiZZ. (2014) Improved 1-deoxynojirimycin (DNJ) production in mulberry leaves fermented by microorganism. Brazilian Journal of Microbiology, 45, 721–729.
43.
LiuWJ, ZhaoJ, GaoXM, LiuMP, ZengS. (2009) Study on the extraction and purification of DNJ from Morus alba L. (Article in Chinese). Chinese Archives of Traditional Chinese Medicine, 10, 2079–2081.
44.
LuoLL, WuJ. (2012) Isolation and purification of 1-deoxynojirimycin from Morus alba L. leaves (Article in Chinese). Modern Food Science and Technology, 28, 167–169.
45.
WangT, LiCQ, ZhangH, LiJW. (2014) Response surface optimized extraction of 1-deoxynojirimycin from mulberry leaves (Morus alba L.) and preparative separation with resins. Molecules, 19, 7040–7056
46.
ChenY, ZhangW, ZhaoT, LiF, ZhangM, LiJ, ZouY, WangW, CobbinaSJ, WuX, YangL. (2016) Adsorption properties of macroporous adsorbent resins for seperation of anthocyanins from mulberry. Food Chemistry, 194, 712–722.
47.
LiuC, XuL, ShiZQ, HeZL, LanJ. (2014) Progress in separation and purification technology of 1-deoxynojirimycin from plants (Article in Chinese). Science Sericulture, 3, 544–550.
48.
XuB, ZhangDY, LiuZY, ZhangY, LiuL, LiL, LiuCC, WuGH. (2015) Rapid determination of 1-deoxynojirimycin in Morus alba L. leaves by direct analysis in real time (DART) mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis, 114, 447–454.
49.
AsanoN, TomiokaE, KizuH, OsekiK, MatsuiK. (1994) Sugars with nitrogen in the ring isolated from the leaves of Morus bombycis. Carbohydrate Research, 253, 235–245
50.
AsanoN, OsekiK, TomiokaE, KizuH, MatsuiK. (1994) N-containing sugars from Morus alba and their glycosidase inhibitory activities. Carbohydrate Research, 259, 243–255.
51.
YoshimizuM, TajimaY, MatsuzawaF, AikawaS, IwamotoK, KobayashiT, EdmundsT, FujishimaK, TsujiD, ItohK, IkekitaM, KawashimaI, SugawaraK, OhyanagiN, SuzukiT, TogawaT, OhnoK, SakurabaH. (2008) Binding parameters and thermodynamics of the interaction of imino sugars with a recombinant human acid alpha-glucosidase (alglucosidase alfa): insight into the complex formation mechanism. Clinica Chimica Acta, 391, 68–73.
52.
DoHJ, ChungJH, HwangJW, KimOY, LeeJY, ShinMJ. (2015) 1-Deoxynojirimycin isolated from Bacillus subtilis improves hepatic lipid metabolism and mitochondrial function in high-fat-fed mice. Food and Chemical Toxicology, 75, 1–7
53.
KwonHJ, ChungJY, KimJY, KwonO. (2011) Comparison of 1-deoxynojirimycin and aqueous mulberry leaf extract with emphasis on postprandial hypoglycemic efects: in vivo and in vitro studies. Journal of Agricultural and Food Chemistry, 59, 3014–3019.
54.
MiyaharaC, MiyazawaM, SatohS, SakaiA, MizusakiS. (2004) Inhibitory effects of mulberry leaf extract on postprandial hyperglycemia in normal rats. J Journal of Nutritional Science and Vitaminology (Tokyo), 50, 161–164
55.
KimGN, KwonY, JangHD. (2011) Mulberry leaf extract reduces postprandial hyperglycemia with few side effects by inhibiting α-glucosidase in normal rats. Journal of Medicinal Food, 14, 712–717.
56.
AsaiA, NakagawaK, HiguchiO, KimuraT, KojimaY, KariyaJ, MiyazawaT, OikawaS. (2011) Effect of mulberry leaf extract with enriched 1-deoxynojirimycin content on postprandial glycemic control in subjects with impaired glucose metabolism. Journal of Diabetes Investigation, 2, 318–323
57.
VichasilpC, NakagawaK, SookwongP, HiguchiO, KimuraF, MiyazawaT. (2012) A novel gelatin crosslinking method retards release of mulberry 1-deoxynojirimycin providing a prolonged hypoglycaemic effect. Food Chemistry, 134, 1823–1830.
58.
ZhangJ, WanXC, CuiZ, LiuCL. (2012) The research progress of sugar-mimic alkaloids in mulberry (Article in Chinese). Journal of Anhui Agricultural University, 6, 993–997.
59.
KongWH, OhSH, AhnYR, KimKW, KimJH, SeoSW. (2008) Antiobesity effects and improvement of insulin sensitivity by 1-deoxynojirimycin in animal models. Journal of Agricultural and Food Chemistry, 56, 2613–2619
60.
LiuQ, LiX, LiC, ZhengY, PengG. (2015) 1-Deoxynojirimycin alleviates insulin resistance via activation of insulin signaling PI3K/AKT pathway in skeletal muscle of db/db mice. Molecules, 20, 21700–21714.
61.
AhlqvistE, van ZuydamNR, GroopLC, McCarthyMI. (2016) The genetics of diabetic complications. Nature Reviews Nephrology, 11, 277–287
MichaelJ, FowlerMD. (2008) Microvascular and macrovascular complications of diabetes. Clinical Diabetes, 26, 77–82
64.
SaikatS, RajaC, BiplabD. (2016) Complications of diabetes mellitus. In Diabetes Mellitus in 21st Century. Springer Singapore, Singapore, 69–100.
65.
ShalevA, Siegrist-KaiserCA, YenPM, WahliW, BurgerAG, ChinWW, MeierCA. (1996) The peroxisome proliferator-activated receptor alpha is a phosphoprotein: regulation by insulin. Endocrinology, 137, 4499–4502
66.
IpE, FarrellGC, RobertsonG, HallP, KirschR, LeclercqI. (2003) Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice. Hepatology, 38, 123–132
67.
SugdenMC, BulmerK, GibbonsGF, KnightBL, HolnessMJ. (2002) Peroxisome-proliferator-activated receptor-alpha (PPARalpha) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin. Biochemical Journal, 364, 361–368
68.
JiaY, WuC, KimJ, KimB, LeeSJ. (2016) Astaxanthin reduces hepatic lipid accumulations in high-fat-fed C57BL/6J mice via activation of peroxisome proliferator-activated receptor (PPAR) alpha and inhibition of PPAR gamma and Akt. Journal of Nutritional Biochemistry, 28, 9–18.
69.
ViolletB, MounierR, LeclercJ, YazigiA, ForetzM, AndreelliF. (2007) Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders. Diabetes and Metabolism, 33, 395–402.
70.
ForetzM, TaleuxN, GuigasB, HormanS, BeauloyeC, AndreelliF, BertrandL, ViolletB. (2006) Regulation of energy metabolism by AMPK: a novel therapeutic approach for the treatment of metabolic and cardiovascular diseases. Medical Sciences (Paris), 22, 381–388
71.
ViolletB, GuigasB, LeclercJ, HébrardS, LantierL, MounierR, AndreelliF, ForetzM. (2009) AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives. Acta Physiologica, 196, 81–98.
ChanKC, LinMC, HuangCN, ChangWC, WangCJ. (2013) Mulberry 1-deoxynojirimycin pleiotropically inhibits glucose-stimulated vascular smooth muscle cell migration by activation of AMPK/RhoB and down-regulation of FAK. Journal of Agricultural and Food Chemistry, 61, 9867–9875.
75.
KuglerA. (1999) Matrix metalloproteinases and their inhibitors. Anticancer Research, 19, 1589–1592
76.
FigueiraRC, GomesLR, NetoJS, SilvaFC, SilvaID, SogayarMC. (2009) Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential. BMC Cancer, 9, 20–31
77.
ChaveyC, MariB, MonthouelMN, BonnafousS, AnglardP, Van ObberghenE, Tartare-DeckertS. (2003) Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. Journal of Biological Chemistry, 278, 11888–11896
78.
MaquoiE, MunautC, ColigeA, CollenD, LijnenHR. (2002) Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes, 51, 1093–1101.
79.
WangRJ, YangCH, HuML. (2010) 1-Deoxynojirimycin inhibits metastasis of B16F10 melanoma cells by attenuating the activity and expression of matrix metalloproteinases-2 and –9 and altering cell surface glycosylation. Journal of Agricultural and Food Chemistry, 58, 8988–8993.
80.
WenCW, LinXD, DongMJ, DengMJ. (2016) An evaluation of 1-deoxynojirimycin oral administration in Eri silkworm through fat body metabolomics based on 1H nuclear magnetic resonance. BioMed Research International, 4676505.
81.
NojimaH, KimuraI, ChenFJ, SugiharaY, HarunoM, KatoA, AsanoN. (1998) Antihyperglycemic effects of N-containing sugars from Xanthocercis zambesiaca, Morus bombycis, Aglaonema treubii, and Castanospermum australe in streptozotocin diabetic mice. Journal of Natural Products, 61, 397–400.
82.
JungeB, MatzkeM, StoltefussJ. (1996) Chemistry and structure-activity relationships of glucosidase inhibitors. Oral Antidiabetics, 119, 411–482.
83.
WennekesT, van den BergRJ, DonkerW, van der MarelGA, StrijlandA, AertsJM, OverkleeftHS. (2007) Development of adamantan-1-yl-methoxy-functionalized 1-deoxynojirimycin derivatives as selective inhibitors of glucosylceramide metabolism in man. The Journal of Organic Chemistry, 72, 1088–1097.
84.
KaiserT, SawickiPT. (2003) Acarbose for patients with hypertension and impaired glucose tolerance. The Journal of the American Medical Association, 290, 3067–3069
85.
ChiassonJL. (2006) Acarbose for the prevention of diabetes, hypertension, and cardiovascular disease in subjects with impaired glucose tolerance: the Study to Prevent Non-Insulin-Dependent Diabetes Mellitus (STOP-NIDDM) Trial. Endocrine Practice, 12, 25–30.
86.
HiroseT, TeramotoT, AbeK, TaneyamaT. (2015) Determinants of bezafibrate-induced improvements in LDL cholesterol in dyslipidemic patients with diabetes. Journal of Atherosclerosis and Thrombosis, 22, 71–76
87.
MatthewsK. (2006) Bezafibrate decreases the incidence and delays the onset of type 2 diabetes. Nature Clinical Practice Cardiovascular Medicine, 1, 9–10
88.
OgawaS, TakeuchiK, SugimuraK, FukudaM, LeeR, ItoS, SatoT. (2000) Bezafibrate reduces blood glucose in type 2 diabetes mellitus. Metabolism, 49, 331–334.
89.
FukayaN, MochizukiK, TanakaY, KumazawaT, JiuxinZ, FuchigamiM, GodaT. (2009) The alpha-glucosidase inhibitor miglitol delays the development of diabetes and dysfunctional insulin secretion in pancreatic beta-cells in OLETF rats. European Journal of Pharmacology, 624, 51–57
90.
YokoyamaH, KannnoS, IshimuraI, NodeK. (2007) Miglitol increases the adiponectin level and decreases urinary albumin excretion in patients with type 2 diabetes mellitus. Metabolism, 56, 1458–1463
91.
HamadaY, NagasakiH, FuchigamiM, FurutaS, SeinoY, NakamuraJ, OisoY. (2013) The alpha-glucosidase inhibitor miglitol affects bile acid metabolism and ameliorates obesity and insulin resistance in diabetic mice. Metabolism, 62, 734–742.
92.
CampbellLK, BakerDE, CampbellRK. (2000) Miglitol: assessment of its role in the treatment of patients with diabetes mellitus. Annals of Pharmacotherapy, 34, 1291–1301.
93.
MaDQ, JiangZH, XuSQ, YuX, HuXM, PanHY. (2008) Effects of flavonoids in Morus indica on blood lipids and glucose in hyperlipidemia-diabetic rats. Journal of Agricultural and Food Chemistry, 56, 3377–3380
94.
ChenLL, LiuW, ChenJG, BuWL. (2010) Effects of Cydonia oblonga Miller leaf and fruit flavonoids on blood lipids and anti-oxidant potential in hyperlipidemia rats. Strait Pharmaceutical Journal, 22, 24–27.
95.
WangQ, WangR, WangC, LongJ. (2014) Effects of mulberry polysaccharides on glucose metabolism and their antioxidant activities in vitro. Food Science, 35, 260–264
96.
LuGB, RenCJ, CuiWZ, WangY W, GaoHJ, MuZM. (2011) The preliminary structure of polysaccharide MLP II from mulberry leaves and its hypoglycemic effect on rat model of diabetes (Article in Chinese). Science Sericulture, 37, 1053–1060.
97.
XueCY, LiuYH, ZhangRX, ZhengZX, ZhangYH, JingHJ, ZhangY, OuyangH, EugeneC. (2007) Effects of flavonoids from Morus alba L. on activity of alpha-glucosidase. Journal of Clinical Rehabilitative Tissue Engineering Research, 21, 4191–4193.
98.
LiYG, JiDF, ZhongS, LvZQ, LinTB, ChenS, HuGY. (2011) Hybrid of 1-deoxynojirimycin and polysaccharide from mulberry leaves treat diabetes mellitus by activating PDX-1/insulin-1 signaling pathway and regulating the expression of glucokinase, phosphoenolpyruvate carboxykinase and glucose–6-phosphatase in alloxan-induced diabetic mice. Journal of Ethnopharmacology, 134, 961–970
99.
LiYG, JiDF, ZhongS, LinTB, LvZQ. (2015) Hypoglycemic effect of deoxynojirimycin-polysaccharide on high fat diet and streptozotocin-induced diabetic mice via regulation of hepatic glucose metabolism. Chemico-Biological Interactions, 225, 70–79
100.
LiYG, JiDF, ZhongS, LvZQ, LinTB. (2013) Cooperative anti-diabetic effects of deoxynojirimycin-polysaccharide by inhibiting glucose absorption and modulating glucose metabolism in streptozotocin-induced diabetic mice. PLOS ONE, 8, 65892.
101.
VichasilpaC, NakagawabK, SookwongbP, HiguchicO, LuemunkongdS, MiyazawaT. (2012) Development of high 1-deoxynojirimycin (DNJ) content mulberry tea and use of response surface methodology to optimize tea-making conditions for highest DNJ extraction. LWT-Food Science and Technology, 45, 226–232
102.
BanuS, JabirNR, ManjunathNC, KhanMS, AshrafGM, KamalMA, TabrezS. (2015) Reduction of post-prandial hyperglycemia by mulberry tea in type-2 diabetes patients. Saudi Journal of Biological Sciences, 22, 32–36
103.
WilsonRD, IslamMS. (2015) Effects of white mulberry (Morus alba) leaf tea investigated in a type 2 diabetes model of rats. Acta Poloniae Pharmaceutica, 72, 153–160.
104.
WattanathornJ, MuchimapuraS, ThukhammeeW, Tong-unT, WannanonP, PhunchagoN, KaewkaenP, ChantesT, KaewruangW, PimpasaleeS, WongareonwanakijS. (2012) Mulberry fruits protects against age-related cognitive decline. American Journal of Applied Sciences, 9, 1503–1511
105.
ChenC, YouLJ, AbbasiAM, FuX, LiuRH. (2015) Characterization of polysaccharide fractions in mulberry fruit and assessment of their antioxidant and hypoglycemic activities in vitro. Oral Oncology, 51, 139–145.
106.
WangLL, ZhouZY. (2008) Effect of extracts of mulberry leaves processed differently on the activity of alpha-glucosidase. Journal of Food Agriculture and Environment, 6, 86–89.
107.
RyuKS, LeeHS, KimSY. (1999) Pharmacodynamic study of silkworm powder in mice administered to maltose, sucrose and lactose. Korean Journal of Sericulture Science, 41, 9–13
108.
HanJ, InoueS, IsodaH. (2007) Effects of silkworm powder on glucose absorption by human intestinal epithelial cell line Caco-2. Journal of Natural Medicine, 61, 387–390.
